1. Home
  2. CXAI vs IRIX Comparison

CXAI vs IRIX Comparison

Compare CXAI & IRIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CXApp Inc.

CXAI

CXApp Inc.

HOLD

Current Price

$0.36

Market Cap

17.8M

Sector

Technology

ML Signal

HOLD

Logo IRIDEX Corporation

IRIX

IRIDEX Corporation

HOLD

Current Price

$1.14

Market Cap

20.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CXAI
IRIX
Founded
N/A
1989
Country
United States
United States
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
17.8M
20.2M
IPO Year
N/A
1996

Fundamental Metrics

Financial Performance
Metric
CXAI
IRIX
Price
$0.36
$1.14
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
2.9M
66.7K
Earning Date
11-12-2025
11-11-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$5,222,000.00
$50,647,000.00
Revenue This Year
N/A
$9.61
Revenue Next Year
$70.21
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
4.58
52 Week Low
$0.35
$0.78
52 Week High
$2.54
$1.89

Technical Indicators

Market Signals
Indicator
CXAI
IRIX
Relative Strength Index (RSI) 36.47 67.30
Support Level $0.37 $0.95
Resistance Level $0.41 $1.07
Average True Range (ATR) 0.06 0.06
MACD 0.00 0.02
Stochastic Oscillator 9.08 85.19

Price Performance

Historical Comparison
CXAI
IRIX

About CXAI CXApp Inc.

CXApp Inc is a provider of AI-powered employee experience solutions, delivering enterprise-grade software that enhances workplace engagement, productivity, and operational efficiency. The company's flagship product, the CXAI Platform, provides a comprehensive suite of tools designed to empower employees and enable organizations to create smarter workplaces. The product's key components include CXAI Apps, CXAI BTS, and CXAI-VU. The company generates the majority of its revenue from Licenses.

About IRIX IRIDEX Corporation

IRIDEX Corp is involved in the business of developing, manufacturing, and marketing laser-based medical systems, delivery devices, and consumable instrumentation for ophthalmology. Its products include Lasers, Laser delivery devices, Glaucoma devices, Retinal surgical instruments, and Veterinary and ENT products. The firm also powers its products with its proprietary Micropulse technology. The company operates in only one reportable segment, Ophthalmology. It derives revenues from the sale of consoles, delivery devices, consumables, services, and support activities. The geographical segments of the company include the United States, which drives maximum revenue, Europe, and the Americas, excluding the U.S. and Asia/Pacific Rim.

Share on Social Networks: